Search Results - "Strijbos, M H"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Circulating endothelial cells in oncology: pitfalls and promises by Strijbos, M H, Gratama, J W, Kraan, J, Lamers, C H, Bakker, MA den, Sleijfer, S

    Published in British journal of cancer (03-06-2008)
    “…Adequate blood supply is a prerequisite in the pathogenesis of solid malignancies. As a result, depriving a tumour from its oxygen and nutrients, either by…”
    Get full text
    Journal Article
  2. 2

    Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel by Strijbos, M.H, Gratama, J.W, Schmitz, P.I.M, Rao, C, Onstenk, W, Doyle, G.V, Miller, M.C, de Wit, R, Terstappen, L.W.M.M, Sleijfer, S

    Published in European journal of cancer (1990) (01-07-2010)
    “…Abstract Purpose We investigated whether serum markers of angiogenesis endothelin-1 (ET-1) and tissue factor (TF), and/or markers of vascular damage such as…”
    Get full text
    Journal Article
  3. 3

    CIRCULATING TUMOUR CELLS AND CIRCULATING ENDOTHELIAL CELLS AS BIOMARKERS IN ONCOLOGY by Strijbos, MH

    Published in Acta clinica belgica (English ed. Online) (01-09-2011)
    “…Circulating tumour cells (CTC) and circulating endothelial cells (CEC) are considered promising biomarkers for tumour aggressiveness and vascular damage. Their…”
    Get full text
    Journal Article
  4. 4
  5. 5

    A new approach for rapid and reliable enumeration of circulating endothelial cells in patients by KRAAN, J., STRIJBOS, M. H., SIEUWERTS, A. M., FOEKENS, J. A., DEN BAKKER, M. A., VERHOEF, C., SLEIJFER, S., GRATAMA, J. W.

    Published in Journal of thrombosis and haemostasis (01-05-2012)
    “…Background:  Mature circulating endothelial cells (CECs) are surrogate markers of endothelial damage/dysfunction. A lack of standardized assays and consensus…”
    Get full text
    Journal Article
  6. 6

    mRNA levels of CD31, CD144, CD146 and von Willebrand factor do not serve as surrogate markers for circulating endothelial cells by Strijbos, Michiel H, van Krimpen, Brigitte A, Debets, Reno, Kraan, Jaco, Sleijfer, Stefan, Gratama, Jan Willem, Lamers, Cor H J

    Published in Thrombosis and haemostasis (01-08-2010)
    “…Circulating endothelial cells (CEC) are considered a promising marker to determine the extent of vascular damage. However, currently available and validated…”
    Get more information
    Journal Article
  7. 7